Media Newsroom of

Greystone Research Associates

98 Route 101A
Amherst, NH 03031
Phone: 603-595-4340
Website: http://www.greystoneassociates.org

Greystone Research Associates is a medical technology consulting firm supplying guidance, direction and market knowledge to Pharmaceutical and Biotech companies.

Driven by Demographics and Economics Subcutaneous Injection Markets to Reach 7 Billion Units in 2024

Driven by Demographics and Economics Subcutaneous Injection Markets to Reach 7 Billion Units in 2024

The evolution in drug-injection devices to accommodate new injectable drugs continues to change the therapeutic drug landscape. Device designers are now building on the experience of earlier generations of syringes and injectors, incorporating new design features with the aim of…

Dual Chamber Injection Device Market to Reach $5.3 Billion by 2024

Dual Chamber Injection Device Market to Reach $5.3 Billion by 2024

The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients have led to increasing interest in injection devices that can eliminate the number of steps required to convert…

Greystone Research Associates: Self Injection Systems Adapting to Address the Dosing Challenges of Evolving Therapeutics

Greystone Research Associates: Self Injection Systems Adapting to Address the Dosing Challenges of Evolving Therapeutics

In response to new and emerging drug classes, evolving formulations and patient safety initiatives, the injectable drug segment has seen a marked increase in the level of drug/device integration and feature expansion, according to Greystone Research Associates. Some of these…

Convergence of Sensor Enabled Devices and Predictive Data Set to Advance Chronic Respiratory Patient Care

Convergence of Sensor Enabled Devices and Predictive Data Set to Advance Chronic Respiratory Patient Care

Converging technologies are creating new ways for patients diagnosed with chronic upper respiratory illnesses to improve outcomes while avoiding external factors that may exacerbate or trigger their conditions. These complementary patient care modalities, most of which are in the early…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login